𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

✍ Scribed by E. Millefiorini; C. Gasperini; C. Pozzilli; F. D’Andrea; S. Bastianello; M. Trojano; S. Morino; V. Brescia Morra; A. Bozzao; A. Calo’; M. L. Bernini; D. Gambi; M. Prencipe

Publisher
Springer
Year
1997
Tongue
English
Weight
44 KB
Volume
244
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Magnetic resonance imaging results of th
Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis
✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp